Venaxis Acquires BiOptix Diagnostics

genomeweb
360dx

Venaxis Acquires BiOptix Diagnostics

Sep 14, 2016

NEW YORK (GenomeWeb) – Diagnostics developer Venaxis announced late Tuesday that it has acquired a privately-held Colorado-based company called BiOptix Diagnostics.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

Insecticide Resistance Marker in Malaria Vector Tracks With Reduced Efficacy of Treated Bednets
Mutations Affecting Histones Could Contribute to Tumorigenesis, New Study Finds
TRACERx Study Characterizes Immune Relationship to Lung Tumor Evolution
Early Migrations to Canary Islands Untangled with Ancient Mitochondrial DNA
NanoString Technologies Prices $103.5M Common Stock Offering
Interpace Diagnostics Posts 32 Percent Increase in Q4 Revenues

The Scan

Push for Predictive Genetic Tests

Matt Hancock, the UK health secretary, is calling for the swift rollout of predictive genetic tests, the Guardian reports.

Gene-Editing Registry Proposed

A WHO panel is calling for a global registry of human germline gene-editing projects, according to Stat News.

Sneaking Out of the Lab

Vox writes that lab mishaps involving pathogens are quite common.

This Week in Genome Biology

In Genome Biology this week: analysis of wild and cultivated peach genomes, Hi-C-based pipeline for assembling microbial genomes from metagenomic data, and more.

Menu